Table 2. Clinical factors for anti-seizure medication adherence among adult Epileptic patients at Eka Kotebe General Hospital, Ethiopia, 2023 (n = 357).
Variable | Category | Frequency | Percentage |
---|---|---|---|
Age of onset of Epilepsy (Year) (Median, IQR) | 17(10,24) | ||
Duration of illness (in Years) | <5 years | 48 | 13.4 |
6–10 years | 82 | 23 | |
>11 years | 223 | 62.5 | |
Types of Seizure | Generalized | 279 | 78.2 |
Focal | 66 | 18.5 | |
Unclassified | 12 | 3.4 | |
Number of ASMs | Monotherapy | 227 | 63.6 |
Polytherapy | 130 | 36.4 | |
History of Adverse effects of ASMs that prompt to stop taking medication | No | 283 | 79.3 |
Yes | 74 | 20.7 | |
History of Adverse effects of ASMs that prompt to stop taking medication since the last visit | No | 340 | 95.2 |
Yes | 17 | 4.8 | |
Comorbidity | No | 308 | 86.3 |
Yes | 49 | 13.7 |